![]() ![]() |
EMORY | |||||||||||||||||||||||||||||
| MATERNAL SUBSTANCE ABUSE AND CHILD DEVELOPMENT | ||||||||||||||||||||||||||||||
|
Statins and Pregnancy The United States Food and Drug Administration have classified cholesterol-lowering drugs, or statins, as pregnancy category X, which means these drugs are not supposed to be taken by pregnant women. Recently, some birth defects specialists are concerned about the possibility of cholesterol-lowering drugs becoming available over-the-counter to a wide range of women of child bearing age. According to researchers with the March of Dimes, there is a hypothesized link between the use of statins during pregnancy and a set of birth defects. Although it is extremely unlikely that a doctor would prescribe a statin to a pregnant patient, a woman might unknowingly become pregnant while taking a statin. Related Documents:
More to come...
Emory West 1256 Briarcliff Road, Room-323 West, Atlanta GA 30306
|
The Maternal Substance Abuse and Child Development Study is under the direction of Claire D. Coles Ph.D., with the Department of Psychiatry and Behavioral Science, Emory University School of Medicine. For more information, please contact: Claire D. Coles: ccoles@emory.edu ; Karen K. Howell: khowell@emory.edu |
||||||||||||||||||||||||||||
| Copyright © | Privacy | Best previewed with IE 5 / NS 4.7 and higher | ||||||||||||||||||||||||||||